Kilitch Drugs (India) Limited
NSE: KILITCH.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mukund Prataprai Mehta
- Employees
- 168
- Headquarters
- Mumbai, India
- IPO year
- 2010
- Market cap
- ₹5.6B
- Website
- https://www.kilitch.com
Loading KILITCH…
Loading profile data…Frequently asked questions about KILITCH
What does Kilitch Drugs (India) Limited (KILITCH.NS) do?
Kilitch Drugs (India) Limited engages in the development and operation of pharmaceutical business in India. The company offers parenteral and nasal products, including gastroenterology, anti-inflammatory, anticonvulsant/antiepileptic, anti-malarial, aminoglycoside, antibacterial, anti-hypertensive, anti-infective, diagnostic, sympathomimetic, lo...
Where does KILITCH.NS trade?
Kilitch Drugs (India) Limited (KILITCH.NS) trades on the National Stock Exchange of India.
What sector is KILITCH.NS in?
Kilitch Drugs (India) Limited (KILITCH.NS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Kilitch Drugs (India) Limited?
Mukund Prataprai Mehta is the chief executive officer of Kilitch Drugs (India) Limited (KILITCH.NS).
Where is Kilitch Drugs (India) Limited headquartered?
Kilitch Drugs (India) Limited is headquartered in India.
Does KILITCH.NS pay a dividend?
Kilitch Drugs (India) Limited (KILITCH.NS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did KILITCH.NS go public?
Kilitch Drugs (India) Limited (KILITCH.NS) completed its initial public offering in 2010.